RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Sabzali Javadov to Cardiomyopathies

This is a "connection" page, showing publications Sabzali Javadov has written about Cardiomyopathies.
Connection Strength

0.832
  1. Khuchua Z, Glukhov AI, Strauss AW, Javadov S. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases. Int J Mol Sci. 2018 Nov 04; 19(11).
    View in: PubMed
    Score: 0.637
  2. Huang Y, Powers C, Moore V, Schafer C, Ren M, Phoon CK, James JF, Glukhov AV, Javadov S, Vaz FM, Jefferies JL, Strauss AW, Khuchua Z. The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome. Orphanet J Rare Dis. 2017 03 09; 12(1):49.
    View in: PubMed
    Score: 0.142
  3. Dzhavadov SA, Dzhokharidze TZ, Dzhaliashvili IV, Gel'fgat EB, Saks VA, Pogacha G. [Energy metabolism and contractile function of the heart in diabetic cardiomyopathy: effect of ischemia and reperfusion]. Biokhimiia. 1992 Dec; 57(12):1917-29.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support